A number of bacterial natural products contain substituted ???-unsaturated-?-lactones. The chemical nature of the substituents alters the biological activity considerably. For natural products such as fostriecin and phoslactomycins (PLMs), the ?-substituent is a linear polyketide chain and unusual in that it has multiple cis double bonds and a phosphate group. The PLMs exhibit remarkably selectivity and potent activity against human fungal pathogens, including Aspergillus fumigatus. The DNA encoding the PLM and fostriecin biosynthetic processes have been cloned, sequenced and analyzed. It has been shown that both natural products are generated by modular polyketide synthases (PKSs). In the case of PLM much of the biosynthetic process has been deciphered. The knowledge and genetic tools provided through ongoing PLM biosynthetic studies has allowed the generation of blocked mutants, hybrid pathways, and mutasynthetic approaches to access new natural products based around the PLM skeleton. These compounds are generally obtained in excellent fermentation yield (10-50 mg/L) from fermentations and include significant structural diversity both around the lactone core and in the delta substituent. Additional structural variation has been obtained by chemical and efficient enzymatic modification of these new PLM core structures. The proposal has 4 aims.
Aim 1 will test a hypothesis for how modules in both systems establish the unusual cis double bonds in the ?-substituent.
Aim 2 -3 will test a hypothesis that the cis double bond of the unsaturated lactone, is not established by a canonical dehydration domain within a PKS module, but rather an unprecedented decarboxylative elimination from a malonylated pathway intermediate. A series of chemical, biochemical, genetic and structural approaches will investigate the enzyme-catalyzed elimination reaction, determine how the malonylated intermediate is generated, and the sequence of these steps in the PLM biosynthetic pathway.
Aims 4 will focus on evaluating the antifungal activity of new PLMs, and the basis for their selective antifungal activity.
Bacteria produce a small family of chemically related natural products such as fostriecin and phoslactomycin with established anticancer and antifungal activity. This project will combine modern techniques such as genetic engineering, organic and enzyme-catalyzed synthesis to 1) understand how these natural products are made, and 2) generate new structurally-related compounds for potential application in human-health issues.
|Bonnett, Shilah A; Whicher, Jonathan R; Papireddy, Kancharla et al. (2013) Structural and stereochemical analysis of a modular polyketide synthase ketoreductase domain required for the generation of a cis-alkene. Chem Biol 20:772-83|
|Liu, Yuan; Hazzard, Christopher; Eustáquio, Alessandra S et al. (2009) Biosynthesis of salinosporamides from alpha,beta-unsaturated fatty acids: implications for extending polyketide synthase diversity. J Am Chem Soc 131:10376-7|
|Eustaquio, Alessandra S; McGlinchey, Ryan P; Liu, Yuan et al. (2009) Biosynthesis of the salinosporamide A polyketide synthase substrate chloroethylmalonyl-coenzyme A from S-adenosyl-L-methionine. Proc Natl Acad Sci U S A 106:12295-300|
|Ghatge, Mohini S; Palaniappan, Nadaraj; Alhamadsheh, Ma'moun M et al. (2009) Application of a newly identified and characterized 18-o-acyltransferase in chemoenzymatic synthesis of selected natural and nonnatural bioactive derivatives of phoslactomycins. Appl Environ Microbiol 75:3469-76|
|Palaniappan, Nadaraj; Alhamadsheh, Mamoun M; Reynolds, Kevin A (2008) cis-Delta(2,3)-double bond of phoslactomycins is generated by a post-PKS tailoring enzyme. J Am Chem Soc 130:12236-7|
|Alhamadsheh, Mamoun M; Palaniappan, Nadaraj; Daschouduri, Suparna et al. (2007) Modular polyketide synthases and cis double bond formation: establishment of activated cis-3-cyclohexylpropenoic acid as the diketide intermediate in phoslactomycin biosynthesis. J Am Chem Soc 129:1910-1|
|Ghatge, Mohini; Palaniappan, Nadaraj; Das Choudhuri, Suparna et al. (2006) Genetic manipulation of the biosynthetic process leading to phoslactomycins, potent protein phosphatase 2A inhibitors. J Ind Microbiol Biotechnol 33:589-99|
|Ghatge, Mohini S; Reynolds, Kevin A (2005) The plmS2-encoded cytochrome P450 monooxygenase mediates hydroxylation of phoslactomycin B in Streptomyces sp. strain HK803. J Bacteriol 187:7970-6|
|Choudhuri, Suparna Das; Ayers, Sloan; Soine, William H et al. (2005) A pH-stability study of phoslactomycin B and analysis of the acid and base degradation products. J Antibiot (Tokyo) 58:573-82|